价格

Search documents
特一药业: 2024年度分红派息实施公告
Zheng Quan Zhi Xing· 2025-07-17 10:22
股份 13,729,618 股后的股本 498,932,248 股为基数,按分配比例不变的原则,向全体 股东每 10 股派发现金红利 0.500000 元(含税),不送红股,不以公积金转增股本。 的总金额为 24,946,612.40 元(实际现金分红的总金额=实际参与分配的总股本×每股 分配比例,即 24,946,612.40 元=498,932,248 股×0.0500000 元/股)。因公司已购回 的股份不参与分红,实施权益分派前后公司总股本保持不变,现金分红总额分摊到每一 股的比例将减小。因此,本次权益分派实施后除权除息价格计算时,按公司总股本(含 回购专户股份)折算的每股现金红利应以 0.0486609 元(含税,保留七位小数,最后一 位直接截取,不四舍五入)计算(每股现金红利=现金分红总额/总股本,即 0.0486609 元/股=24,946,612.40 元÷512,661,866 股)。 在保证本次利润分配方案不变的前提下,2024 年度权益分派实施后的除权除息价 格按照上述原则及计算方式执行,即本次权益分派实施后的除权除息价格=除权除息日 的前一交易日收盘价-0.0486609 元/股。 特 ...
磷酸铁锂成本临“拐点”
高工锂电· 2025-07-17 10:21
Core Viewpoint - The article highlights the increasing cost pressures on lithium iron phosphate (LFP) production due to rising prices of key raw materials, particularly ferrous sulfate, which is influenced by the declining operating rates in the titanium dioxide industry [2][3]. Group 1: Industry Dynamics - The titanium dioxide industry is experiencing a decline in operating rates, currently at 65.83% as of June 2025, down over 12 percentage points since April, leading to a tightening supply of ferrous sulfate [2]. - The current market price for ferrous sulfate has risen to 1800-1900 RMB per ton, driven by low inventory levels, which may soon surpass the cost levels of iron powder-based processes [2]. - Approximately two-thirds of the iron sources used in domestic LFP production come from ferrous sulfate, indicating its critical role in the cost structure of LFP manufacturing [2]. Group 2: Cost Structure Sensitivity - The cost structure of LFP is highly dependent on the stability of raw material markets, which include iron, phosphorus, and lithium sources, making it sensitive to price fluctuations in upstream industries [3]. - The pricing mechanism in the LFP industry is primarily based on lithium pricing, which is influenced by the average monthly price of battery-grade lithium carbonate, but increasing volatility in phosphorus and iron prices could compress profit margins if not managed effectively [3]. Group 3: Strategic Responses - There is a growing consensus among LFP companies to integrate upstream resources to mitigate cost pressures, with companies like Hunan Youneng securing phosphate resources in Guizhou for self-supply and Longpan Technology partnering with CATL to establish a lithium carbonate processing plant [4].
【期货热点追踪】棕榈油期价刷新阶段高点,政策红利驱动生物燃料需求,未来价格涨势能否持续?
news flash· 2025-07-17 09:52
期货热点追踪 棕榈油期价刷新阶段高点,政策红利驱动生物燃料需求,未来价格涨势能否持续? 相关链接 ...
7月17日电,印度石油部长表示,如果原油价格保持在当前水平,印度可能会下调燃油价格。
news flash· 2025-07-17 09:42
智通财经7月17日电,印度石油部长表示,如果原油价格保持在当前水平,印度可能会下调燃油价格。 ...
印度石油部长:如果未来两到三个月原油价格保持在当前水平,燃料价格有望下调。
news flash· 2025-07-17 09:36
印度石油部长:如果未来两到三个月原油价格保持在当前水平,燃料价格有望下调。 ...
黄金未来三种情形推演!世界黄金协会发布重磅报告
Jin Shi Shu Ju· 2025-07-17 09:31
据世界黄金协会的贵金属分析师称,未来18个月,黄金价格的前景偏向上行,而白银和铂金预计将在 2026年之前延续其近期的强势。 世界黄金协会前景预测组的高级经济学家Jeetendra Khadan和研究分析师Kaltrina Temaj写道,"贵金属价 格在2025年上半年飙升至历史新高,这是在2024年上涨20%的基础之上,这轮涨势由黄金引领,在美元 走弱、利率区间波动以及高度不确定的地缘经济环境下,投资需求强劲。" "黄金作为表现最佳的主要资产类别之一,结束了上半年,期间上涨了近26%,"他们指出。"它在2025 年上半年创下了26个历史新高,此前在2024年已突破了40个新高。" 分析师们表示,这种优异表现是多种因素综合作用的结果,包括美元走弱、因预期未来降息而导致的收 益率区间波动,以及"加剧的地缘政治紧张局势——其中一些与美国贸易政策直接或间接相关。" "更强的需求也来自于场外交易市场(OTC)、交易所和ETF交易活动的增加,"他们说。"这使得上半 年黄金日均交易量达到3290亿美元——创下有记录以来的半年度最高数字。各国央行也以强劲的步伐持 续购买,做出了贡献——即使没有达到前几个季度的创纪录水平。 ...
血透费用跌破三百,CT也降价了
Hu Xiu· 2025-07-17 08:55
Core Insights - The article discusses the significant reduction in medical service prices in China, particularly focusing on hemodialysis costs, which have dropped below 300 yuan, benefiting over one million dialysis patients [1][3][5] Group 1: Hemodialysis Price Reform - In 2024, the number of patients requiring dialysis in China is projected to reach 1.027 million, highlighting the critical need for affordable treatment options [1] - The National Healthcare Security Administration (NHSA) has issued guidelines to consolidate hemodialysis pricing, reducing the number of pricing items from 421 to 108, aiming to eliminate duplicate charges [3][8] - Provinces like Guangdong and Hunan have already implemented new pricing structures, with Guangdong setting a maximum price for hemodialysis at 390 yuan per session, while Hunan has established a base price of 330 yuan [5][7] Group 2: Broader Medical Service Price Reforms - The ongoing medical service price reform is not limited to hemodialysis but encompasses various medical services, with the NHSA aiming to standardize pricing across provinces to address historical discrepancies [8][9] - The NHSA has published 28 batches of project guidelines covering various medical fields, leading to significant price reductions in services such as ultrasound and PET/CT scans [9] - The reforms are designed to enhance transparency in medical pricing, preventing healthcare institutions from imposing additional charges under different names [7][9]
五粮液“破防”?有电商平台售价低至748元
2 1 Shi Ji Jing Ji Bao Dao· 2025-07-17 08:53
Core Viewpoint - The prices of premium liquors, particularly Wuliangye, have significantly dropped following a price decline in Feitian Moutai, indicating a potential shift in the high-end liquor market dynamics [1][4][5]. Price Trends - Wuliangye's price on e-commerce platforms has fallen below 750 yuan, with specific listings showing prices as low as 748 yuan for the 52-degree 500ml bottle [1]. - The wholesale reference price for Wuliangye's eighth generation has decreased by 5.26% from the beginning of the year, dropping from 950 yuan to 900 yuan per bottle [5]. - Feitian Moutai has seen price declines exceeding 10%, with the 25-year-old bottle now priced at 1870 yuan, down from 2200 yuan, marking a 15% drop [5]. Market Dynamics - The decline in Moutai prices is expected to exert pressure on other high-end liquor brands, particularly Wuliangye, leading to potential price compression and demand diversion [5]. - There are concerns that the price drop of Moutai may trigger panic selling in distribution channels, further deteriorating the sales expectations for Wuliangye and other premium liquors [5]. - Wuliangye's official communication has warned consumers about counterfeit products being sold under the guise of discounts and promotions on various platforms, emphasizing the importance of purchasing from authorized sellers [4].
【安泰科】单晶硅片周评--原料价格上行 带动硅片价格跳涨(2025年7月17日)
中国有色金属工业协会硅业分会· 2025-07-17 08:14
Group 1 - The price of silicon wafers has started to rise significantly this week, with N-type G10L monocrystalline wafers averaging 1.05 yuan per piece, up 22.09% week-on-week; N-type G12R wafers at 1.15 yuan, up 15.00%; and N-type G12 wafers at 1.35 yuan, up 13.45% [1] - The main reasons for the increase in silicon wafer prices are the continuous rise in silicon material prices and an improvement in the supply-demand relationship for silicon wafers. The price of polysilicon has been rising due to policies affecting the industry, which has led to an increase in wafer prices [1] - Silicon wafer manufacturers have begun to implement production reduction and load reduction plans this month, leading to a decrease in industry supply and providing strong motivation for price increases as inventory levels drop [1] Group 2 - Downstream battery prices have slightly increased, with mainstream battery prices at 0.24-0.25 yuan per watt, up 0.01 yuan week-on-week, while module prices remain stable at 0.65-0.66 yuan per watt [2] - Although terminal demand has not shown significant improvement, rising silicon material prices driven by policy factors are expected to transmit to downstream segments [2] - Silicon wafer companies have reached a preliminary consensus on new pricing, with expected prices for N-type G10L at 1.45 yuan per piece, N-type G12R at 1.65 yuan, and N-type G12 at 1.93 yuan, with leading silicon wafer manufacturers holding back inventory in anticipation of price increases [2]